• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌联合美沙拉嗪及乙乙白头翁汤保留灌肠治疗轻中度溃疡性结肠炎的临床观察

Clinical observation of probiotics combined with mesalazine and Yiyi Baitouweng Decoction retention enema in treating mild-to-moderate ulcerative colitis.

作者信息

Li Yanlong, Li Baoyu, Gou Yuqin, Tian Xudong, Chang Lijun, Qu Chaoxu

机构信息

Diagnosis and Treatment Center for Spleen and Stomach Diseases, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730030, Gansu, China.

College of Integrated Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, Gansu, China.

出版信息

Open Med (Wars). 2025 Feb 25;20(1):20241126. doi: 10.1515/med-2024-1126. eCollection 2025.

DOI:10.1515/med-2024-1126
PMID:40028263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11868706/
Abstract

OBJECTIVE

The purpose of this article was to unravel the clinical efficacy of probiotics combined with mesalazine and Yiyi Baitouweng Decoction retention enema in the treatment of mild-to-moderate ulcerative colitis (UC).

METHODS

Eighty-six mild-to-moderate UC patients were selected as study subjects and randomized into the control group (treated with mesalazine enteric-coated tablets [Salofalk]) and the observation group (treated with mesalazine enteric-coated tablets, Bifidobacterium Tetravaccine Tablets, and Yiyi Baitouweng Decoction retention enema). The clinical efficacy, colonoscopy score, serum levels of inflammatory factors, and the incidence of adverse reactions were compared.

RESULTS

The clinical efficacy of patients in the observation group was better in contrast to the control group. After 8 weeks of treatment, the colonoscopy score, and levels of TNF-α, IFN-γ, CRP, and ESR were lower, while IL-10 levels were higher in patients of both groups than those before treatment; lower colonoscopy score and levels of TNF-α, IFN-γ, CRP, and ESR and higher IL-10 levels were observed in the observation group versus the control group.

CONCLUSION

Probiotics combined with mesalazine and Yiyi Baitouweng Decoction retention enema have remarkable clinical effects in treating mild-to-moderate UC.

摘要

目的

本文旨在探讨益生菌联合美沙拉嗪及乙乙白头翁汤保留灌肠治疗轻至中度溃疡性结肠炎(UC)的临床疗效。

方法

选取86例轻至中度UC患者作为研究对象,随机分为对照组(采用美沙拉嗪肠溶片[莎尔福]治疗)和观察组(采用美沙拉嗪肠溶片、双歧杆菌四联活菌片及乙乙白头翁汤保留灌肠治疗)。比较两组的临床疗效、结肠镜评分、血清炎症因子水平及不良反应发生率。

结果

观察组患者的临床疗效优于对照组。治疗8周后,两组患者的结肠镜评分、肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)、C反应蛋白(CRP)及血沉(ESR)水平均低于治疗前,白细胞介素-10(IL-10)水平均高于治疗前;与对照组相比,观察组患者的结肠镜评分、TNF-α、IFN-γ、CRP及ESR水平更低,IL-10水平更高。

结论

益生菌联合美沙拉嗪及乙乙白头翁汤保留灌肠治疗轻至中度UC具有显著临床效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1b/11868706/cec09bc6f673/j_med-2024-1126-ga001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1b/11868706/cec09bc6f673/j_med-2024-1126-ga001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1b/11868706/cec09bc6f673/j_med-2024-1126-ga001.jpg

相似文献

1
Clinical observation of probiotics combined with mesalazine and Yiyi Baitouweng Decoction retention enema in treating mild-to-moderate ulcerative colitis.益生菌联合美沙拉嗪及乙乙白头翁汤保留灌肠治疗轻中度溃疡性结肠炎的临床观察
Open Med (Wars). 2025 Feb 25;20(1):20241126. doi: 10.1515/med-2024-1126. eCollection 2025.
2
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.丙酸倍氯米松与美沙拉嗪治疗远端溃疡性结肠炎的多中心、随机、双盲研究
Dig Liver Dis. 2007 Apr;39(4):329-37. doi: 10.1016/j.dld.2007.01.012. Epub 2007 Mar 7.
3
Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.美沙拉嗪泡沫剂(莎尔福泡沫剂)治疗活动期远端溃疡性结肠炎。与莎尔福灌肠剂的对比试验。SAF - 3研究组。
Ital J Gastroenterol Hepatol. 1999 Nov;31(8):677-84.
4
Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Active Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study.美沙拉嗪缓释片治疗活动期溃疡性结肠炎的中国多中心单盲随机对照研究
Adv Ther. 2016 Mar;33(3):400-9. doi: 10.1007/s12325-016-0303-z. Epub 2016 Feb 22.
5
Efficacy and safety of BaitouWeng decoction for ulcerative colitis: A meta-analysis of randomized and controlled trials.白头翁汤治疗溃疡性结肠炎的疗效和安全性:一项随机对照试验的荟萃分析。
Medicine (Baltimore). 2024 Jul 5;103(27):e38704. doi: 10.1097/MD.0000000000038704.
6
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.对于广泛性轻度/中度活动性溃疡性结肠炎患者,口服与灌肠联合使用颇得斯安(美沙拉嗪)治疗优于单纯口服治疗:一项随机、双盲、安慰剂对照研究。
Gut. 2005 Jul;54(7):960-5. doi: 10.1136/gut.2004.060103.
7
Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis: A protocol for randomized, double-blind, controlled trial.康妇消炎栓联合美沙拉嗪灌肠对活动期溃疡性结肠炎育龄女性妊娠结局及生活质量的影响:一项随机、双盲、对照试验方案。
Medicine (Baltimore). 2021 Feb 5;100(5):e23915. doi: 10.1097/MD.0000000000023915.
8
Distribution of mesalazine enemas in active and quiescent ulcerative colitis.美沙拉嗪灌肠剂在活动期和静止期溃疡性结肠炎中的分布情况。
Aliment Pharmacol Ther. 1996 Jun;10(3):327-32. doi: 10.1111/j.0953-0673.1996.00327.x.
9
Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study.美沙拉嗪泡沫灌肠剂(莎尔福泡沫剂)治疗远端溃疡性结肠炎的疗效和耐受性:一项双盲、随机、安慰剂对照研究。
Aliment Pharmacol Ther. 2000 Sep;14(9):1191-8. doi: 10.1046/j.1365-2036.2000.00784.x.
10
A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial.一种新型美沙拉嗪凝胶灌肠剂治疗左侧溃疡性结肠炎:一项随机对照多中心试验
Aliment Pharmacol Ther. 1999 Mar;13(3):381-8. doi: 10.1046/j.1365-2036.1999.00482.x.

引用本文的文献

1
LianChuang ZhiXue Liquid Enema Modulates the Macrophage Polarization of Ulcerative Colitis via Inhibiting the Jagged-1/Notch1 Signaling Pathway.连创止泻液灌肠通过抑制Jagged-1/Notch1信号通路调节溃疡性结肠炎巨噬细胞极化
Drug Des Devel Ther. 2025 Apr 26;19:3253-3268. doi: 10.2147/DDDT.S503483. eCollection 2025.

本文引用的文献

1
Five commonly used traditional Chinese medicine formulas in the treatment of ulcerative colitis: A network meta-analysis.治疗溃疡性结肠炎的五种常用中药方剂:网状Meta分析
World J Clin Cases. 2024 Aug 6;12(22):5067-5082. doi: 10.12998/wjcc.v12.i22.5067.
2
Baitouweng decoction alleviates ulcerative colitis by regulating tryptophan metabolism through DOPA decarboxylase promotion.白头翁汤通过促进多巴脱羧酶调节色氨酸代谢来减轻溃疡性结肠炎。
Front Pharmacol. 2024 Jun 21;15:1423307. doi: 10.3389/fphar.2024.1423307. eCollection 2024.
3
Efficacy and safety of BaitouWeng decoction for ulcerative colitis: A meta-analysis of randomized and controlled trials.
白头翁汤治疗溃疡性结肠炎的疗效和安全性:一项随机对照试验的荟萃分析。
Medicine (Baltimore). 2024 Jul 5;103(27):e38704. doi: 10.1097/MD.0000000000038704.
4
Retracted: Efficacy and Safety of Bifidobacterium Quadruple Viable Bacteria Combined with Mesalamine against UC Management: A Systematic Review and Meta-Analysis.撤回:双歧杆菌四联活菌联合美沙拉嗪治疗溃疡性结肠炎的疗效与安全性:一项系统评价与Meta分析
Oxid Med Cell Longev. 2023 Dec 29;2023:9826531. doi: 10.1155/2023/9826531. eCollection 2023.
5
Baitouweng decoction alleviates dextran sulfate sodium-induced ulcerative colitis by suppressing leucine-related mTORC1 signaling and reducing oxidative stress.白头翁汤通过抑制亮氨酸相关的 mTORC1 信号和减少氧化应激来缓解葡聚糖硫酸钠诱导的溃疡性结肠炎。
J Ethnopharmacol. 2023 Mar 25;304:116095. doi: 10.1016/j.jep.2022.116095. Epub 2022 Dec 26.
6
Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitis.美沙拉嗪治疗轻中度溃疡性结肠炎的优化使用建议。
Br J Hosp Med (Lond). 2021 Oct 2;82(10):1-11. doi: 10.12968/hmed.2021.0399. Epub 2021 Oct 26.
7
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.欧洲克罗恩病和结肠炎组织(ECCO)溃疡性结肠炎治疗指南:药物治疗
J Crohns Colitis. 2022 Jan 28;16(1):2-17. doi: 10.1093/ecco-jcc/jjab178.
8
Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients.补充双歧三联活菌胶囊治疗可改善溃疡性结肠炎患者的炎症反应和 T 细胞频率。
BMC Gastroenterol. 2021 Aug 4;21(1):314. doi: 10.1186/s12876-021-01887-2.
9
Ulcerative colitis: an update.溃疡性结肠炎:最新进展。
Clin Med (Lond). 2021 Mar;21(2):135-139. doi: 10.7861/clinmed.2021-0080.
10
Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.溃疡性结肠炎的诊断和治疗算法。
Dtsch Arztebl Int. 2020 Aug 17;117(33-34):564-574. doi: 10.3238/arztebl.2020.0564.